News | Robotic Systems | January 06, 2016

Corindus Launches CorPath Robotic-Assisted Coronary Intervention Program at Mass General

Collaboration will improve visualization and accuracy while increasing physician safety

Corindus, MGH, Massachusetts General, CorPath System, robotic-assisted coronary intervention program

January 6, 2016 — Corindus Vascular Robotics Inc. announced the launch of a CorPath robotic-assisted coronary intervention program at Massachusetts General Hospital (MGH) and the installation of its first CorPath System. Involvement in the robotic-assisted coronary intervention program will allow physicians at MGH to perform percutaneous coronary interventions (PCI) using the CorPath System while protected from radiation exposure in the system's radiation-shielded control cockpit.

The CorPath System is the first and only U.S. Food and Drug Administration (FDA)-cleared medical device to bring robotic-assisted precision to PCI procedures while protecting medical professionals from radiation exposure occurring in hospital catheterization laboratories. The CorPath robotic-assisted coronary intervention program at MGH brings the safety and benefits of the CorPath System to cath lab patients and workers today, as well as creating opportunities for furthering the technology in the future.

"Emerging technologies should contribute to the well-being of patients and physicians," said Doug Drachman, M.D., director of MGH’s Cardiovascular Fellowship Program. "Robotic assistance provides enhanced visualization and potentially increased accuracy. Coupled with radiation reduction for clinicians, these advances may not only improve care, but also the long-term health of patient and provider."

Today, interventional procedures performed in hospital cath labs are a leading source of radiation exposure for medical personnel, which has been linked to the development of cataracts, cancer, and brain and thyroid diseases. The CorPath System allows interventional cardiologists to perform procedures in a protected cockpit just a few feet away from the patient bedside. Seated in the radiation-protected cockpit, the physician uses intuitive digital controls to robotically advance guidewires, angioplasty balloons and stents through coronary arteries.

For more information: www.corindus.com

Related Content

Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Ra Medical Systems Granted Broad Patent for DABRA Catheter
News | Peripheral Artery Disease (PAD)| August 09, 2017
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
Abbott Initiates XIENCE Short DAPT Clinical Trial
News | Antiplatelet and Anticoagulation Therapies| August 03, 2017
Abbott recently announced the first patient has been enrolled in a clinical study evaluating the short-term use of...
Overlay Init